47
Pharma & HealthcareHold
Bajaj Finserv Healthcare
Bajaj Finserv · Direct–Growth · rank #11 of 19 by Smart Score
Data updated
Trailing returns
1 Year
14.1%
+18.8% vs index
3 Years
—
5 Years
—
Since launch
7.0%
Year-by-year performance
2025
-2.9%-10.6% vs index
2026
+16.2%+22.2% vs index
Why this score
Bajaj Finserv Healthcare scores 47/100 — #11 of 19 Pharma & Healthcare fund (Hold). It stands out for volatility and expense ratio — beating 84% of peers on volatility. The main drag is its sharpe ratio (better than only 9% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
Sharpe ratio0.04 · 9th percentile in category
Volatility13.51 · 84th percentile in category
Sortino ratio0.05 · 10th percentile in category
Expense ratio0.90% · 82nd percentile in category
Fund size405.14 Cr · 24th percentile in category
1Y return14.10% · 74th percentile in category
Top holdings
1.Divi's Laboratories Ltd9.75%
2.Sun Pharmaceutical Industries Ltd8.96%
3.Piramal Pharma Ltd6.36%
4.Rubicon Research Ltd.6.08%
5.Aurobindo Pharma Ltd6.03%
33 disclosed equity positions · portfolio as of Sept 2026 · weights are % of total corpus.